✦ LIBER ✦

Molecular-targeted therapies for ovarian cancer: prospects for the future

✍ Scribed by Sudo, Tamotsu

Book ID: 115456683
Publisher: Springer
Year: 2012
Tongue: English
Weight: 358 KB
Volume: 17
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-012-0461-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular-targeted therapies for ovarian

Molecular-targeted therapies for ovarian cancer

✍ Kigawa, Junzo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 76 KB

Targeted therapy for epithelial ovarian

Targeted therapy for epithelial ovarian cancer: Current status and future prospects

✍ H. T. See; J. J. Kavanagh; W. Hu; R. C. Bast JR. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Molecular targeted therapies for pancrea

Molecular targeted therapies for pancreatic cancer

✍ Daniel Borja-Cacho; Eric Hans Jensen; Ashok Kumar Saluja; Donald J. Buchsbaum; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 657 KB

Novel molecular targeted therapies for r

Novel molecular targeted therapies for refractory thyroid cancer

✍ Cesar A. Perez; Edgardo S. Santos; Belisario A. Arango; Luis E. Raez; Ezra E. W. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

Clinical trials and future potential of

Clinical trials and future potential of targeted therapy for ovarian cancer

✍ Itamochi, Hiroaki; Kigawa, Junzo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 274 KB

Clinical trials and future potential of

Clinical trials and future potential of targeted therapy for ovarian cancer

✍ Itamochi, Hiroaki; Kigawa, Junzo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 274 KB

Ovarian cancer is the leading cause of death in women with gynecological cancer. Most patients are diagnosed at an advanced stage with a poor prognosis. Currently, surgical tumor debulking followed by chemotherapy based on platinum and taxane is the standard treatment for advanced disease. However,